Last reviewed · How we verify

NCT05464901

VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern China

Completed Last updated 19 July 2022
What this trial tests

trial in Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Anticoagulants in 500 participants. Completed in 1 November 2018.

Timeline
1 December 2006
Primary endpoint
1 July 2018
1 November 2018

Quick facts

Lead sponsorWei Huang
StatusCompleted
Study typeOBSERVATIONAL
Enrollment500
Start date1 December 2006
Primary completion1 July 2018
Estimated completion1 November 2018

Conditions studied

Sponsor

Wei Huang

Who can join

Eligibility, any sex, with Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Anticoagulants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Little is known about the current management status of venous thromboembolism (VTE) in Southwestern China. We aimed to investigate the status of anticoagulant administration in VTE in Southwestern China and assess the potential predictors of deep vein thrombosis (DVT) complicated pulmonary embolism (PE). We extracted data from YiduCloud database from December 2006 to November 2018 and performed a cross-sectional survey of VTE. The demographics, laboratory tests, and anticoagulants were collected and analyzed in the logistic regression model, classification tree and Random Forest model.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Wei Huang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing